CHRA Trademark

Trademark Overview

On Tuesday, October 21, 2025, a trademark application was filed for CHRA with the United States Patent and Trademark Office. The USPTO has given the CHRA trademark a serial number of 99455118. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, October 21, 2025. This trademark is owned by Lumeris Solutions Company, LLC. The CHRA trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Telemedicine services; Medical services, namely, providing Artificial Intelligence (AI)-supported primary care services
chra

General Information

Serial Number99455118
Word MarkCHRA
Filing DateTuesday, October 21, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateTuesday, October 21, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesTelemedicine services; Medical services, namely, providing Artificial Intelligence (AI)-supported primary care services

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, October 21, 2025
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLumeris Solutions Company, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMaryland Heights, MO 63043

Trademark Events

Event DateEvent Description
Tuesday, October 21, 2025NEW APPLICATION ENTERED
Tuesday, October 21, 2025APPLICATION FILING RECEIPT MAILED

Related Keywords

chra services supported primary care intelligence providing medical namely telemedicine artificial